Squarepoint’s Halozyme HALO Stock Holding History

Squarepoint’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.58M	Buy	+32,400	New	+$3.13M	﹤0.01%	1702

Other funds holding HALO

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Squarepoint's HALO Position: Q3 2026 in Review

Squarepoint increased its Halozyme (HALO) stake by 653% in Q3 2026, buying an estimated $23.3M and bringing the position to 278,742 shares worth $30.8M. The position accounts for 0.03% of the portfolio, ranked #486.

Squarepoint first reported a position in HALO in Q4 2014 and has held it in 31 quarters since. 412 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

Squarepoint held 278,742 shares of Halozyme worth $30.8M as of Q3 2026.
Squarepoint bought 241,707 Halozyme shares in Q3 2026, an estimated $23.3M.
Halozyme made up 0.03% of Squarepoint's portfolio in Q3 2026, its #486 holding.
Squarepoint first reported a position in Halozyme in Q4 2014 and has held it in 31 quarters since.
412 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.